ATS GUIDELINES Bundle

IDSA CAP Guidelines

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/88038

Contents of this Issue

Navigation

Page 3 of 11

Diagnosis and Assessment of Disease Evaluation and Initial Management of CAP History, physical examination, chest radiograph No infiltrate: manage/evaluate for alternative diagnosis Infiltrate + compatible clinical features supporting diagnosis of pneumonia* Determine site of care: PSI, CURB-65, clinical judgment (PSI risk classes I, II, III; CURB-65 score 0-1) Manage as outpatient Empirical therapy (Table 4) (eg, frail condition, no response to oral therapy, severe social or psychiatric problems, substance abuse, unstable living situation, homelessness) Mitigating factors Refer to Table 3 for clinical indications for more extensive diagnostic testing General medical ward: antibiotic first dose administered in ED (PSI risk classes III, IV, V; Hospitalize patient CURB-65 score ≥ 2) Refer to Table 2 for criteria for severe CAP ICU: antibiotic first dose administered in ED No pathogen defined or tests pending: • β-Lactam + advanced macrolide OR 2 • Respiratory fluoroquinolone (Table 4) No pathogen defined or tests pending (Pseudomonas infection not an issue): • β-Lactam + advanced macrolide OR • β-Lactam + respiratory fluoroquinolone (Table 4) *Compatible clinical features include but are not limited to fever, hypothermia, rigors, sweats, new cough with/without sputum production, change in color of secretions, chest discomfort, or onset of dyspnea.

Articles in this issue

view archives of ATS GUIDELINES Bundle - IDSA CAP Guidelines